Literature DB >> 33654163

MAPRE2 mutations result in altered human cranial neural crest migration, underlying craniofacial malformations in CSC-KT syndrome.

Cedric Thues1,2,3, Jorge S Valadas2,3, Liesbeth Deaulmerie2,3, Ann Geens2,3, Amit K Chouhan2,3, Ramon Duran-Romaña4,5, Joost Schymkowitz4,5, Frederic Rousseau4,5, Michaela Bartusel6,7, Rizwan Rehimi6, Alvaro Rada-Iglesias6,8,9, Patrik Verstreken2,3, Hilde Van Esch10.   

Abstract

Circumferential skin creases (CSC-KT) is a rare polymalformative syndrome characterised by intellectual disability associated with skin creases on the limbs, and very characteristic craniofacial malformations. Previously, heterozygous and homozygous mutations in MAPRE2 were found to be causal for this disease. MAPRE2 encodes for a member of evolutionary conserved microtubule plus end tracking proteins, the end binding (EB) family. Unlike MAPRE1 and MAPRE3, MAPRE2 is not required for the persistent growth and stabilization of microtubules, but plays a role in other cellular processes such as mitotic progression and regulation of cell adhesion. The mutations identified in MAPRE2 all reside within the calponin homology domain, responsible to track and interact with the plus-end tip of growing microtubules, and previous data showed that altered dosage of MAPRE2 resulted in abnormal branchial arch patterning in zebrafish. In this study, we developed patient derived induced pluripotent stem cell lines for MAPRE2, together with isogenic controls, using CRISPR/Cas9 technology, and differentiated them towards neural crest cells with cranial identity. We show that changes in MAPRE2 lead to alterations in neural crest migration in vitro but also in vivo, following xenotransplantation of neural crest progenitors into developing chicken embryos. In addition, we provide evidence that changes in focal adhesion might underlie the altered cell motility of the MAPRE2 mutant cranial neural crest cells. Our data provide evidence that MAPRE2 is involved in cellular migration of cranial neural crest and offers critical insights into the mechanism underlying the craniofacial dysmorphisms and cleft palate present in CSC-KT patients. This adds the CSC-KT disorder to the growing list of neurocristopathies.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33654163      PMCID: PMC7925611          DOI: 10.1038/s41598-021-83771-3

Source DB:  PubMed          Journal:  Sci Rep        ISSN: 2045-2322            Impact factor:   4.379


  49 in total

Review 1.  Cranial neural crest cells on the move: their roles in craniofacial development.

Authors:  Dwight R Cordero; Samantha Brugmann; Yvonne Chu; Ruchi Bajpai; Maryam Jame; Jill A Helms
Journal:  Am J Med Genet A       Date:  2010-12-10       Impact factor: 2.802

2.  EB1 and EB3 control CLIP dissociation from the ends of growing microtubules.

Authors:  Yulia Komarova; Gideon Lansbergen; Niels Galjart; Frank Grosveld; Gary G Borisy; Anna Akhmanova
Journal:  Mol Biol Cell       Date:  2005-09-07       Impact factor: 4.138

3.  Circumferential skin creases, cleft palate, typical face, intellectual disability and growth delay: "circumferential skin creases Kunze type".

Authors:  Leen Wouters; Celia Maria Rodriguez Rodriguez; Elena Porta Dapena; Vincent Vander Poorten; Koen Devriendt; Hilde Van Esch
Journal:  Eur J Med Genet       Date:  2011-01-22       Impact factor: 2.708

4.  Seamless genome editing in human pluripotent stem cells using custom endonuclease-based gene targeting and the piggyBac transposon.

Authors:  Kosuke Yusa
Journal:  Nat Protoc       Date:  2013-09-26       Impact factor: 13.491

5.  The FoldX web server: an online force field.

Authors:  Joost Schymkowitz; Jesper Borg; Francois Stricher; Robby Nys; Frederic Rousseau; Luis Serrano
Journal:  Nucleic Acids Res       Date:  2005-07-01       Impact factor: 16.971

6.  YASARA View - molecular graphics for all devices - from smartphones to workstations.

Authors:  Elmar Krieger; Gert Vriend
Journal:  Bioinformatics       Date:  2014-07-04       Impact factor: 6.937

7.  SWISS-MODEL: homology modelling of protein structures and complexes.

Authors:  Andrew Waterhouse; Martino Bertoni; Stefan Bienert; Gabriel Studer; Gerardo Tauriello; Rafal Gumienny; Florian T Heer; Tjaart A P de Beer; Christine Rempfer; Lorenza Bordoli; Rosalba Lepore; Torsten Schwede
Journal:  Nucleic Acids Res       Date:  2018-07-02       Impact factor: 16.971

8.  The EMBL-EBI search and sequence analysis tools APIs in 2019.

Authors:  Fábio Madeira; Young Mi Park; Joon Lee; Nicola Buso; Tamer Gur; Nandana Madhusoodanan; Prasad Basutkar; Adrian R N Tivey; Simon C Potter; Robert D Finn; Rodrigo Lopez
Journal:  Nucleic Acids Res       Date:  2019-07-02       Impact factor: 16.971

9.  Amyloidogenic regions and interaction surfaces overlap in globular proteins related to conformational diseases.

Authors:  Virginia Castillo; Salvador Ventura
Journal:  PLoS Comput Biol       Date:  2009-08-21       Impact factor: 4.475

10.  Regulation of Focal Adhesion Dynamics and Cell Motility by the EB2 and Hax1 Protein Complex.

Authors:  Han Liu; Jiping Yue; He Huang; Xuewen Gou; Shao-Yu Chen; Yingming Zhao; Xiaoyang Wu
Journal:  J Biol Chem       Date:  2015-11-02       Impact factor: 5.157

View more
  3 in total

1.  Gene expression profiling and protein-protein interaction analysis reveals the dynamic role of MCM7 in Alzheimer's disorder and breast cancer.

Authors:  Navneeth Sriram; Sunny Mukherjee; Mahesh Kumar Sah
Journal:  3 Biotech       Date:  2022-06-10       Impact factor: 2.893

Review 2.  Extracellular Matrix in Human Craniofacial Development.

Authors:  D A Cruz Walma; K M Yamada
Journal:  J Dent Res       Date:  2021-12-07       Impact factor: 8.924

3.  Profound Effects of Dexamethasone on the Immunological State, Synthesis and Secretion Capacity of Human Testicular Peritubular Cells.

Authors:  Youli Konstantinovitch Stepanov; Jan Dominik Speidel; Carola Herrmann; Nina Schmid; Rüdiger Behr; Frank-Michael Köhn; Jan Bernd Stöckl; Ulrich Pickl; Matthias Trottmann; Thomas Fröhlich; Artur Mayerhofer; Harald Welter
Journal:  Cells       Date:  2022-10-09       Impact factor: 7.666

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.